TATA Health International Holdings Limited (01255) published its monthly return for the period ended 30 September 2025. The authorized share capital remained at 500,000,000 ordinary shares with a par value of HKD 0.01 each, amounting to a total authorised capital of HKD 5,000,000.
The number of issued shares remained unchanged at 242,845,000 shares. There were no reported treasury shares or adjustments to share options, warrants, convertibles, or other share issuance arrangements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.